Overview
Emerging infectious diseases (EIDs) are newly-identified or previously unrecognized diseases that are increasing in incidence or geographic range around the world. They can be caused by newly discovered or emergent pathogens, those re-emerging due to drug and/or vaccine resistance, or those which have existed in a particular ecological niche and are now affected by human activities. Examples of EIDs include SARS, MERS, Ebola, and Zika virus. EIDs are of particular importance in public health because they are associated with a high risk of morbidity and mortality. Furthermore, they can result in significant economic damage through the disruption of social activities, disruption of the supply of goods and services, and the cost of disease control and management. Therefore, there is a need to develop surveillance and risk management strategies to detect and respond to EIDs in a timely manner.
Research published in this journal
8 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 8 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Qi Li et al. · 2023 · Biosensors
-
2022 · International Journal of Clinical Virology
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2022 · International Journal of Clinical Virology
-
Shengzhe Zhou et al. · 2022 · Microbiology Research
-
F. Adzitey et al. · 2022 · Small Animal Advances
-
CFTR-mediated monocyte/macrophage dysfunction revealed by cystic fibrosis proband-parent comparisons2022 · JCI Insight
-
2022 · Small Animal Advances
A sample of recent works citing this journal's research on Emerging Infectious Diseases, linking to each citing work.